Sodium phenylbutyrate (Pheburane®)

Assessment Status Rapid review complete
HTA ID -
Drug Sodium phenylbutyrate
Brand Pheburane®
Indication As adjunctive therapy in the chronic management of urea cycle disorders, involving deficiencies of carbamylphosphate synthetase, ornithine transcarbamylase or argininosuccinate synthetase.
Assessment Process
Rapid review outcome Full Pharmacoeconomic Evaluation Not Recommended